Ⅲa期非小细胞肺癌患者预后的单中心回顾性分析
段超1, 邢飞21. 中国医科大学本溪市中心医院心胸外科, 辽宁 本溪 117000;
2. 中国医科大学附属盛京医院乳腺外科, 沈阳 110022
收稿日期:
2020-11-11出版日期:
2021-09-30发布日期:
2021-09-18通讯作者:
段超E-mail:duanchao2003@126.com作者简介:
段超(1984-),男,副主任医师,硕士.基金资助:
国家自然科学基金(81701570)关键词: 非小细胞肺癌, T分期, N分期, 临床预后
Abstract: Objective To explore the prognosis of stage Ⅲa non-small cell lung cancer (NSCLC) patients following the 8th TNM classification. Methods We retrospectively analyzed the clinical data of 215 stage Ⅲa NSCLC patients who underwent lung resection at Benxi Central Hospital and did not accept any postoperative adjuvant therapy from 2001 to 2010. The patients were divided into four subgroups (pT2aN2M0,pT2bN2M0,pT3N1M0,and pT4N1M0),and the prognosis of the patients were analyzed and compared. Results Significant differences in the 5-year survival rates were found among the four subgroups:between pT2aN2M0 and pT3N1M0,between pT2bN2M0 and pT3N1M0,and between pT3N1M0 and pT4N1M0 (P<0.05). However,no significant difference in the 5-year survival rates was found between squamous cell carcinoma and adenocarcinoma patients. Additionally,the 5-year survival rates in patients with intermediate differentiation were significantly higher than those with high differentiation (P<0.05),and the 5-year survival rates in patients with vessel and pleural invasion were significantly lower than those without vessel and pleural invasion (P<0.05). Conclusion The subclassification of stage Ⅲa NSCLC has prominent prognostic significance,and thus it is recommended that the current stage should be subclassified to predict patient prognosis with greater accuracy.
Key words: non-small cell lung cancer, T stage, N stage, clinical prognosis
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=2832